GLAXOSMITHKLINE PHARMA A/S — Credit Rating and Financial Key Figures

GLAXOSMITHKLINE PHARMA A/S (CVR number: 27394019) is a company from VALLENSBÆK. The company reported a net sales of 474.5 mDKK in 2023, demonstrating a growth of 7.8 % compared to the previous year. The operating profit percentage was at 3.3 % (EBIT: 15.7 mDKK), while net earnings were 12 mDKK. The profitability of the company measured by Return on Assets (ROA) was 13.7 %, which can be considered good but Return on Equity (ROE) was 32.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 32.3 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. GLAXOSMITHKLINE PHARMA A/S's liquidity measured by quick ratio was 1.4 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.